These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9878559)

  • 1. Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding protein.
    Kumar KN; Johnson PS; Chen X; Pal R; Ahmad M; Ragland T; Bigge C; Michaelis EK
    Biochem Biophys Res Commun; 1998 Dec; 253(2):463-9. PubMed ID: 9878559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
    Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
    J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A partial agonist model used in the allosteric modulation of the NMDA receptor.
    Robichon R; Randall PK; Leslie SW
    Eur J Pharmacol; 1997 Jun; 328(2-3):255-63. PubMed ID: 9218709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
    Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
    J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits.
    Kendrick SJ; Lynch DR; Pritchett DB
    J Neurochem; 1996 Aug; 67(2):608-16. PubMed ID: 8764586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
    Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
    Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of [3H]CGP 39653 binding to NMDA receptors by a P2 antagonist, suramin.
    Balcar VJ; Dias LS; Li Y; Bennett MR
    Neuroreport; 1995 Dec; 7(1):69-72. PubMed ID: 8742419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
    Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
    Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies on binding of 3 different ligands to the N-methyl-D-aspartate recognition domain in brain synaptic membranes treated with Triton X-100.
    Zuo P; Ogita K; Han D; Yoneda Y
    Brain Res; 1993 Apr; 609(1-2):253-61. PubMed ID: 8099522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two affinity states of N-methyl-D-aspartate recognition sites: modulation by cations.
    Mukhin A; Kovaleva ES; London ED
    J Pharmacol Exp Ther; 1997 Aug; 282(2):945-54. PubMed ID: 9262362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphenyl-derivatives of 2-amino-7-phosphonoheptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonist--I. Pharmacological characterization in vitro.
    Urwyler S; Laurie D; Lowe DA; Meier CL; Müller W
    Neuropharmacology; 1996 Jun; 35(6):643-54. PubMed ID: 8887974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
    Dumont M; Lemaire S
    Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
    Oblin A; Schoemaker H
    Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain.
    Mugnaini M; Giberti A; Ratti E; van Amsterdam FT
    J Neurochem; 1993 Oct; 61(4):1492-7. PubMed ID: 8104234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide.
    Terse PS; Komiskey HL
    Brain Res; 1997 Jan; 744(2):347-50. PubMed ID: 9027396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.